Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Net Margin (2020 - 2025)

Bioventus (BVS) has disclosed Net Margin for 5 consecutive years, with 10.97% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin changed N/A year-over-year to 10.97%, compared with a TTM value of 4.8% through Dec 2025, changed N/A, and an annual FY2025 reading of 4.8%, changed N/A over the prior year.
  • Net Margin was 10.97% for Q4 2025 at Bioventus, up from 2.89% in the prior quarter.
  • Across five years, Net Margin topped out at 29.99% in Q2 2021 and bottomed at 62.51% in Q2 2023.
  • Average Net Margin over 4 years is 6.22%, with a median of 0.34% recorded in 2022.
  • The sharpest move saw Net Margin soared 1666bps in 2021, then tumbled -6217bps in 2023.
  • Year by year, Net Margin stood at 0.02% in 2021, then crashed by -96890bps to 18.59% in 2022, then plummeted by -236bps to 62.51% in 2023, then soared by 118bps to 10.97% in 2025.
  • Business Quant data shows Net Margin for BVS at 10.97% in Q4 2025, 2.89% in Q3 2025, and 6.28% in Q2 2025.